NEPHROLOGY / CLINICAL RESEARCH
Key technical aspects and vascular access safety in membrane-based therapeutic plasma exchange for the pediatric population
More details
Hide details
1
Department of Pediatric Nephrology and Hypertension, University Children’s Hospital, Cracow, Poland
2
Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Cracow, Poland
3
Department of Electronics, Faculty of Computer Science, Electronics and Telecommunications, AGH University of Science and Technology, Cracow, Poland
4
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Cracow, Poland
Submission date: 2025-01-07
Final revision date: 2025-06-25
Acceptance date: 2025-07-09
Online publication date: 2025-08-23
Publication date: 2026-04-12
Corresponding author
Monika Miklaszewska
Department of Pediatric Nephrology and Hypertension
Jagiellonian University Medical College
Cracow, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Therapeutic plasma exchange (TPE) is a widely used extracorporeal blood purification procedure. While its principles are similar across age groups, the technical complexity and risks are heightened in pediatric patients due to unique technical considerations. This study assessed the safety regarding both technical and clinical complications of vascular access and membrane-based TPE filters in a pediatric population at a single center.
Material and methods:
This retrospective cohort study reviewed charts of patients undergoing TPE at a level 3 referral center over 25 years.
Results:
The study involved 178 patients undergoing a total of 740 procedures during 214 sessions, predominantly using femoral vascular access. The median duration of the entire TPE sessions (treated as a surrogate for catheter lifespan) was 118.5 hours. Technical complications occurred in 20.8% of procedures (31.6% of events), while clinical complications occurred in 4.2% (4.7% of events). Technical complications were nearly five times more frequent than clinical complications, with technical events being 6.7 times more common. The proportion of patients experiencing clinical complications was 15.2%. Logistic regression demonstrated that each additional day of catheter placement increased the probability of technical complications by 3%. Additionally, each year of patient age decreased the likelihood of clinical complications by 8.9%, while fresh frozen plasma (FFP) supplementation within a session increased the probability of clinical complications by 21.6%.
Conclusions:
Prolonged catheter use increases technical events, while FFP supplementation elevates catheter-related clinical complication risk. Advancing patient age reduces the likelihood of clinical complications, underscoring age-specific safety considerations in pediatric TPE.
REFERENCES (32)
1.
Lu J, Zhang L, Xia C, Tao Y. Complications of therapeutic plasma exchange: A retrospective study of 1201 procedures in 435 children. Medicine (Baltimore) 2019; 98: e18308.
2.
Goldstein SL. Therapeutic apheresis in children: special considerations. Semin Dial 2012; 25: 165-70.
3.
Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 2023; 38: 77-278.
4.
Zachwieja K. Ciągłe Metody Leczenia Nerkozastępczego (continuous renal replacement therapy, CRRT). In: Pediatria. Pietrzyk JJ, Kwinta P (eds.). Wydawnictwo UJ, Kraków 2018; vol. 2: 135-9.
5.
Ismail N, Kiprov DD, Hakim RM. In: Podręcznik dializoterapii. Daugirdas JT, Blake PG, Ing TS (eds.). 2nd edn. Czelej, Lublin 2008; 176-90.
6.
Zachwieja K. Plazmafareza. In: Pediatria. Pietrzyk JJ, Kwinta P (eds.). Wydawnictwo UJ, Kraków 2018; vol. 2: 140-2.
7.
Levy J. Plasma exchange. In: Comprehensive Clinical Nephrology. Johson JR, Feehallt J, Floege J (eds.). 5th edn. Elsevier Saunders, 2010; 1122-30.
8.
Rus RR, Premru V, Novljan G, Grošelj-Grenc M, Ponikvar R. Fate of central venous catheters used for acute extracorporeal treatment in critically ill pediatric patients: a single center experience. Ther Apher Dial 2016; 20: 308-11.
9.
Öztürk AG, Küçük ZE, Özcan S, et al. Use of Therapeutic plasma exchange in the pediatric intensive care unit. Turk Arch Pediatr 2022; 57: 186-92.
10.
Oto A, Kilic N, Kazanci EG, Akaci O, Ekici A. Therapeutic plasma exchange in critically ill pediatric patients. Int J Med Sci Clin Inven 2022; 9: 6333-42.
11.
Özsoylu S, Dursun A, Çelik B. Therapeutic plasma exchange in pediatric intensive care unit: a single-center experience. Indian J Crit Care Med 2021; 25: 1189-92.
12.
Aygün F, Varol F, Durak C, et al. Evaluation of continuous renal replacement therapy and therapeutic plasma exchange, in severe sepsis or septic shock in critically ill children. Medicina (Kaunas) 2019; 55: 350.
13.
Sık G, Demirbuga A, Annayev A, Akcay A, Çıtak A, Öztürk G. Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications. Ther Apher Dial 2020; 24: 221-9.
14.
Atay G, Yazar H, Erdoğan S, Tuğrul HC, İşcan H, Kutlubay B. Therapeutic plasma exchange for treating pediatric neurological diseases. Trends Pediatr 2022; 3: 47-50.
15.
Taylan C, Schaaf A, Dorn C, et al. Safety of therapeutic apheresis in children and adolescents. Front Pediatr 2022; 10: 850819.
16.
Savransky A, Rubstein A, Rios MH, et al. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination. Neurology 2019; 93: e2065-73.
17.
Mörtzell Henriksson M, Newman E, Witt V, et al. Adverse events in apheresis: an update of the WAA registry data. Transfus Apher Sci 2016; 54: 2-15.
18.
Gala-Błądzińska A, Mazur K, Dębiec A, Gargasz K, Bartosik-Psujek H. Safety and tolerability of therapeutic plasma exchange in autoimmune neurological diseases – a retrospective single-centre analysis. Neurol Neurochir Pol 2020; 54: 344-9.
19.
Duyu M, Turkozkan C. Therapeutic plasma exchange in the pediatric intensive care unit: a single-center 5-year experience. Transfus Apher Sci 2020; 59: 102959.
20.
Cortina G, Ojinaga V, Giner T, et al. Therapeutic plasma exchange in children: one center’s experience. J Clin Apher 2017; 32: 494-500.
21.
Lemaire A, Parquet N, Galicier L, et al. Plasma exchange in the intensive care unit: technical aspects and complications. J Clin Apher 2017; 32: 405-12.
22.
Kalenderoğlu MD, Çomak E, Aksoy GK, et al. Therapeutic apheresis: is it safe in children with kidney disease? Pediatr Nephrol 2024; 39: 2451-7.
23.
Reddy SK, Jahan A, Chaturvedi S, Agarwal I. Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience. Clin Kidney J 2015; 8: 702-7.
24.
Mokrzycki MH, Balogun RA. Therapeutic apheresis: a review of complications and recommendations for prevention and management. J Clin Apher 2011; 26: 243-8.
25.
Gafoor VA, Jose J, Saifudheen K, Musthafa M. Plasmapheresis in neurological disorders: Experience from a tertiary care hospital in South India. Ann Indian Acad Neurol 2015; 18: 15-9.
26.
Eyre M, Hacohen Y, Barton C, Hemingway C, Lim M. Therapeutic plasma exchange in paediatric neurology: a critical review and proposed treatment algorithm. Dev Med Child Neurol 2018; 60: 765-79.
27.
Michon B, Moghrabi A, Winikoff R, et al. Complications of apheresis in children. Transfusion 2007; 47: 1837-42.
28.
Runowski D, Prokurat S, Rubik J, Grenda R. Therapeutic plasma exchange in pediatric renal transplantation experience of one decade and 389 sessions. Transplant Proc 2018; 50: 3483-6.
29.
Bobati SS, Naik KR. Therapeutic plasma exchange – an emerging treatment modality in patients with neurologic and non-neurologic diseases. J Clin Diagn Res 2017; 11: EC35-7.
30.
Webb TN, Bell J, Griffin R, Dill L, Gurosky C, Askenazi D. Retrospective analysis comparing complication rates of centrifuge vs membrane-based therapeutic plasma exchange in the pediatric population. J Clin Apher 2022; 37: 263-72.
31.
Kielstein JT, Hafer C, Zimbudzi E, Hawes S. A change for better exchange – from membrane therapeutic plasma exchange to centrifugal therapeutic plasma exchange. Eur Med J 2020; 8 (Suppl. 1): 2-10.
32.
Meyer EK, Wong EC. Pediatric therapeutic apheresis: a critical appraisal of evidence. Transfus Med Rev 2016; 30: 217-22.